Lobbying Activity Report

5285-32215

Designated Filer name: Dennis Chan
Client: Canadian Antimicrobial Innovation Coalition
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? Yes
Letter sent on behalf of the following members of the coalition: Adapsyn Bioscience Inc.
Becton Dickinson Canada Inc.
Bright Angel Therapeutics
DeNovaMed Inc
Diasorin Canada
DynaLife
Fedora Pharmaceuticals Inc.
GlaxoSmithKline Inc.
Johnson & Johnson Inc.
Merck Canada Inc.
Microbion Corporation
Nobelex Biotech Inc.
Nosotech
Paladin Labs
Red Leaf Medical
Roche Canada
SaNOtize Inc.
Shionogi
SterileCare
Verity Pharmaceuticals
bioMérieux Canada inc.
Associated registration: 1186-5285-1
Lobbying Activity date: 2024-01-25
Arranged a meeting: No
Posted date: 2024-02-15

Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, ADM, Ministry of Health, PLBSD - Pharmaceutical, Laboratory & Blood Services Division
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Exploring potential policies to address the growing public health threat of antimicrobial resistance to encourage research, innovation and adoption of novel therapeutics, diagnostics, vaccines and other alternative technologies, as well as policies for innovation in antimicrobial stewardship, surveillance and infection prevention and control.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Industry, Science and Technology
Date Modified: